HU230067B1 - Új piperazin só és eljárás előállítására - Google Patents
Új piperazin só és eljárás előállítására Download PDFInfo
- Publication number
- HU230067B1 HU230067B1 HU0800763A HUP0800763A HU230067B1 HU 230067 B1 HU230067 B1 HU 230067B1 HU 0800763 A HU0800763 A HU 0800763A HU P0800763 A HUP0800763 A HU P0800763A HU 230067 B1 HU230067 B1 HU 230067B1
- Authority
- HU
- Hungary
- Prior art keywords
- acid
- added
- tert
- reaction
- ethyl
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 12
- 150000004885 piperazines Chemical class 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- -1 ester ester Chemical class 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 150000004682 monohydrates Chemical class 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 2
- 235000019441 ethanol Nutrition 0.000 claims description 2
- QMEZUZOCLYUADC-UHFFFAOYSA-N hydrate;dihydrochloride Chemical compound O.Cl.Cl QMEZUZOCLYUADC-UHFFFAOYSA-N 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 239000000543 intermediate Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 238000003756 stirring Methods 0.000 description 19
- 239000000243 solution Substances 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- 239000000203 mixture Substances 0.000 description 16
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000000832 Ayote Nutrition 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- UPEGUUXMAIFUKN-UHFFFAOYSA-N C1CC(NC(=O)O)CCC1CCN1CCN(C=2C(=C(Cl)C=CC=2)Cl)CC1 Chemical compound C1CC(NC(=O)O)CCC1CCN1CCN(C=2C(=C(Cl)C=CC=2)Cl)CC1 UPEGUUXMAIFUKN-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
- VLGWYKOEXANHJT-UHFFFAOYSA-N methylsulfanol Chemical compound CSO VLGWYKOEXANHJT-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N mono-methylamine Natural products NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- WEYVCQFUGFRXOM-UHFFFAOYSA-N perazine Chemical compound C1CN(C)CCN1CCCN1C2=CC=CC=C2SC2=CC=CC=C21 WEYVCQFUGFRXOM-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (23)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0800763A HU230067B1 (hu) | 2008-12-17 | 2008-12-17 | Új piperazin só és eljárás előállítására |
| TW098142934A TWI448455B (zh) | 2008-12-17 | 2009-12-15 | 哌鹽及其製備方法 |
| AU2009329294A AU2009329294B2 (en) | 2008-12-17 | 2009-12-17 | Piperazine salt and a process for the preparation thereof |
| UAA201109013A UA104163C2 (ru) | 2008-12-17 | 2009-12-17 | Соль пиперазина и способ ее получения |
| SI200931453A SI2358690T1 (sl) | 2008-12-17 | 2009-12-17 | Piperazinska sol in postopek za njeno pripravo |
| US13/140,232 US8569496B2 (en) | 2008-12-17 | 2009-12-17 | Piperazine salt and a process for the preparation thereof |
| PL09797145.1T PL2358690T3 (pl) | 2008-12-17 | 2009-12-17 | Sól piperazyny i sposób jej wytwarzania |
| BRPI0923007A BRPI0923007B8 (pt) | 2008-12-17 | 2009-12-17 | Processo para a preparação de dicloridrato trans n-{4-{2-[4-(2,3-diclorofenil)-piperazina-1-il]etil}-ciclohexilamina |
| PT09797145T PT2358690E (pt) | 2008-12-17 | 2009-12-17 | Sal piperazina e um processo para a preparação do mesmo |
| DK09797145.1T DK2358690T3 (en) | 2008-12-17 | 2009-12-17 | Piperazine AND MANUFACTURING METHOD THEREOF |
| HRP20160726TT HRP20160726T1 (hr) | 2008-12-17 | 2009-12-17 | Soli piperazina i postupak za njihovu pripravu |
| PCT/HU2009/000108 WO2010070369A1 (en) | 2008-12-17 | 2009-12-17 | Piperazine salt and a process for the preparation thereof |
| EP09797145.1A EP2358690B1 (en) | 2008-12-17 | 2009-12-17 | Piperazine salt and a process for the preparation thereof |
| EA201170810A EA019024B1 (ru) | 2008-12-17 | 2009-12-17 | Соль пиперазина и способ ее получения |
| MX2011006591A MX2011006591A (es) | 2008-12-17 | 2009-12-17 | Sal de piperazina y procedimiento de preparacion de la misma. |
| CA2743924A CA2743924C (en) | 2008-12-17 | 2009-12-17 | Piperazine salt and a process for the preparation thereof |
| ES09797145.1T ES2573957T3 (es) | 2008-12-17 | 2009-12-17 | Sal de piperazina y procedimiento de preparación de la misma |
| NZ592907A NZ592907A (en) | 2008-12-17 | 2009-12-17 | Piperazine salt and a process for the preparation thereof |
| GEAP200912300A GEP20125711B (en) | 2008-12-17 | 2009-12-17 | Piperazine salt and method for their preparation |
| JP2011541613A JP5735923B2 (ja) | 2008-12-17 | 2009-12-17 | ピペラジン塩およびその調製方法 |
| CN200980150465.2A CN102256953B (zh) | 2008-12-17 | 2009-12-17 | 哌嗪盐及其制备方法 |
| HUE09797145A HUE029667T2 (en) | 2008-12-17 | 2009-12-17 | Piperazine for the preparation of salt and procedure |
| IL212639A IL212639A0 (en) | 2008-12-17 | 2011-05-03 | Piperazine salt and a process for the preparation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0800763A HU230067B1 (hu) | 2008-12-17 | 2008-12-17 | Új piperazin só és eljárás előállítására |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0800763D0 HU0800763D0 (en) | 2009-03-02 |
| HUP0800763A2 HUP0800763A2 (en) | 2010-11-29 |
| HU230067B1 true HU230067B1 (hu) | 2015-06-29 |
Family
ID=89988672
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0800763A HU230067B1 (hu) | 2008-12-17 | 2008-12-17 | Új piperazin só és eljárás előállítására |
| HUE09797145A HUE029667T2 (en) | 2008-12-17 | 2009-12-17 | Piperazine for the preparation of salt and procedure |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE09797145A HUE029667T2 (en) | 2008-12-17 | 2009-12-17 | Piperazine for the preparation of salt and procedure |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8569496B2 (enExample) |
| EP (1) | EP2358690B1 (enExample) |
| JP (1) | JP5735923B2 (enExample) |
| CN (1) | CN102256953B (enExample) |
| AU (1) | AU2009329294B2 (enExample) |
| BR (1) | BRPI0923007B8 (enExample) |
| CA (1) | CA2743924C (enExample) |
| DK (1) | DK2358690T3 (enExample) |
| EA (1) | EA019024B1 (enExample) |
| ES (1) | ES2573957T3 (enExample) |
| GE (1) | GEP20125711B (enExample) |
| HR (1) | HRP20160726T1 (enExample) |
| HU (2) | HU230067B1 (enExample) |
| IL (1) | IL212639A0 (enExample) |
| MX (1) | MX2011006591A (enExample) |
| NZ (1) | NZ592907A (enExample) |
| PL (1) | PL2358690T3 (enExample) |
| PT (1) | PT2358690E (enExample) |
| SI (1) | SI2358690T1 (enExample) |
| TW (1) | TWI448455B (enExample) |
| UA (1) | UA104163C2 (enExample) |
| WO (1) | WO2010070369A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0700353A2 (en) * | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| US7875610B2 (en) * | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
| CA2715760C (en) * | 2008-02-21 | 2017-06-13 | Mitsubishi Tanabe Pharma Corporation | Solid preparation for oral administration of cariprazine hydrochloride |
| AU2009270823B2 (en) | 2008-07-16 | 2014-07-17 | Richter Gedeon Nyrt. | Pharmaceutical formulations containing dopamine receptor ligands |
| HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
| HUP0800766A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
| ITMI20131693A1 (it) * | 2013-10-14 | 2015-04-15 | Chemo Res S L | Derivati della 1,4-cicloesilammina e loro preparazione |
| CN104496854B (zh) * | 2015-01-06 | 2017-09-22 | 上海医药工业研究院 | 3‑环己基‑1,1‑二甲基脲类化合物及其制备方法和应用 |
| HU231173B1 (hu) | 2016-07-08 | 2021-06-28 | Richter Gedeon Nyrt. | Ipari eljárás cariprazine előállítására |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| CN111269199B (zh) * | 2018-12-05 | 2022-04-08 | 浙江京新药业股份有限公司 | 一种卡利拉嗪的制备方法 |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| CN111892556A (zh) * | 2019-05-06 | 2020-11-06 | 北京万全德众医药生物技术有限公司 | 新的卡利拉嗪制备方法 |
| CN110372557B (zh) * | 2019-08-06 | 2021-05-18 | 上海勋和医药科技有限公司 | 环己烷胺类d3/d2受体部分激动剂 |
| CN114539185B (zh) * | 2020-11-24 | 2024-12-24 | 上海新礼泰药业有限公司 | 一种卡利拉嗪及其中间体的制备方法 |
| HUP2100108A1 (hu) | 2021-03-12 | 2022-09-28 | Richter Gedeon Nyrt | Eljárás és berendezés gyógyászatilag alkalmazható piperazin származékok folyamatos áramú, áramlásos konszekutív redukálással történõ elõállítására |
| CN119874636B (zh) * | 2025-01-16 | 2026-07-28 | 鲁南制药集团股份有限公司 | 一种卡利拉嗪的制备方法 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4957921A (en) | 1989-12-06 | 1990-09-18 | Warner-Lambert Company | Substituted cyclohexanols as central nervous system agents |
| US5047406A (en) | 1989-12-06 | 1991-09-10 | Warner-Lambert Co. | Substituted cyclohexanols as central nervous system agents |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| KR100477070B1 (ko) | 1994-03-25 | 2006-04-21 | 이소테크니카 인코포레이티드 | 중수소화작용에의한의약품의효능강화법 |
| US5977110A (en) | 1995-09-22 | 1999-11-02 | Warner-Lambert Company | Substituted cyclohexylamines as central nervous systems agents |
| KR100672186B1 (ko) | 1998-03-31 | 2007-01-19 | 아카디아 파마슈티칼스 인코포레이티드 | 무스카린 수용체에 대해 활성을 갖는 화합물 |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| SE9802208D0 (sv) | 1998-06-22 | 1998-06-22 | Astra Pharma Inc | Novel compounds |
| JP2000191570A (ja) * | 1998-12-24 | 2000-07-11 | Sumitomo Chem Co Ltd | ヒドロキシフェニルプロパノール類の製造法 |
| US6489341B1 (en) | 1999-06-02 | 2002-12-03 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives |
| DE60223506T2 (de) | 2001-02-27 | 2008-09-18 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamatverbindungen zur vorbeugung oder behandlung bipolarer erkrankungen |
| US6566550B2 (en) | 2001-06-21 | 2003-05-20 | Pfizer Inc | Substituted aromatic ethers as inhibitors of glycine transport |
| HU227543B1 (en) * | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
| SE0200301D0 (sv) | 2002-02-01 | 2002-02-01 | Axon Biochemicals Bv | Thio-carbostyril derivative |
| US6833459B2 (en) * | 2002-04-26 | 2004-12-21 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of thiazole intermediate |
| US6919342B2 (en) | 2003-06-05 | 2005-07-19 | Abbott Gmbh & Co. Kg | Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| HU227534B1 (en) | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
| DE102004047517A1 (de) | 2004-09-28 | 2006-03-30 | Merck Patent Gmbh | Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid |
| HUP0500170A3 (en) | 2005-02-03 | 2007-11-28 | Richter Gedeon Nyrt | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
| GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
| JP2008001633A (ja) * | 2006-06-22 | 2008-01-10 | Showa Denko Kk | テトラヒドロピランを溶媒とする塩化アルミニウム存在下での水素化ホウ素化合物による還元反応 |
| HUP0600809A3 (en) * | 2006-10-27 | 2008-09-29 | Richter Gedeon Nyrt | New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them |
| MY148643A (en) | 2007-05-11 | 2013-05-15 | Richter Gedeon Nyrt | Solvate and crystalline forms of carbamoyl-cyclohexane derivatives |
| HU230748B1 (hu) | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
| HUP0700353A2 (en) * | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| HUP0700369A2 (en) | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia |
| HUP0700370A2 (en) | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania |
| CN101790374A (zh) | 2007-08-01 | 2010-07-28 | H.隆德贝克有限公司 | Kcnq钾通道开放剂用于减轻多巴胺能系统受到干扰的障碍或病症的症状或治疗这种障碍或病症的用途 |
| US7875610B2 (en) | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
| CA2715760C (en) | 2008-02-21 | 2017-06-13 | Mitsubishi Tanabe Pharma Corporation | Solid preparation for oral administration of cariprazine hydrochloride |
| AU2009270823B2 (en) | 2008-07-16 | 2014-07-17 | Richter Gedeon Nyrt. | Pharmaceutical formulations containing dopamine receptor ligands |
| HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
| HUP0800766A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
-
2008
- 2008-12-17 HU HU0800763A patent/HU230067B1/hu not_active IP Right Cessation
-
2009
- 2009-12-15 TW TW098142934A patent/TWI448455B/zh active
- 2009-12-17 HU HUE09797145A patent/HUE029667T2/en unknown
- 2009-12-17 GE GEAP200912300A patent/GEP20125711B/en unknown
- 2009-12-17 MX MX2011006591A patent/MX2011006591A/es active IP Right Grant
- 2009-12-17 DK DK09797145.1T patent/DK2358690T3/en active
- 2009-12-17 US US13/140,232 patent/US8569496B2/en active Active
- 2009-12-17 CA CA2743924A patent/CA2743924C/en not_active Expired - Fee Related
- 2009-12-17 WO PCT/HU2009/000108 patent/WO2010070369A1/en not_active Ceased
- 2009-12-17 NZ NZ592907A patent/NZ592907A/xx unknown
- 2009-12-17 SI SI200931453A patent/SI2358690T1/sl unknown
- 2009-12-17 AU AU2009329294A patent/AU2009329294B2/en active Active
- 2009-12-17 JP JP2011541613A patent/JP5735923B2/ja active Active
- 2009-12-17 UA UAA201109013A patent/UA104163C2/ru unknown
- 2009-12-17 ES ES09797145.1T patent/ES2573957T3/es active Active
- 2009-12-17 BR BRPI0923007A patent/BRPI0923007B8/pt active IP Right Grant
- 2009-12-17 HR HRP20160726TT patent/HRP20160726T1/hr unknown
- 2009-12-17 CN CN200980150465.2A patent/CN102256953B/zh active Active
- 2009-12-17 EP EP09797145.1A patent/EP2358690B1/en active Active
- 2009-12-17 PT PT09797145T patent/PT2358690E/pt unknown
- 2009-12-17 PL PL09797145.1T patent/PL2358690T3/pl unknown
- 2009-12-17 EA EA201170810A patent/EA019024B1/ru unknown
-
2011
- 2011-05-03 IL IL212639A patent/IL212639A0/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0800763A2 (en) | Nowel piperazine salt and preparation method thereof | |
| WO2013026391A1 (zh) | 嘧菌酯及其合成中专用中间体的合成方法 | |
| JP2006312632A (ja) | テルミサルタンの調製方法 | |
| CN101220069B (zh) | 脱氧腺苷类化合物的合成方法 | |
| KR102453655B1 (ko) | 아코티아미드의 개선된 제조방법 | |
| CN101333173A (zh) | 化合物n-〔4-(丁醛-4-基)-苯甲酰基〕-l-谷氨酸二甲酯及应用其制备培美曲塞的方法 | |
| CA2553311A1 (en) | Improved process for the preparation of biologically active tetrahydrobenzthiazole derivative | |
| US10974232B2 (en) | Catalyst, method for forming amide bond, and method for producing amide compound | |
| WO2018065924A1 (en) | Intermediates of mitogen-activated protein kinase kinase (map2k or mek) inhibitors and process for their preparation | |
| PL200714B1 (pl) | Sposób wytwarzania 4-(heteroarylo-metylo) -1(2H)-ftalazynonów | |
| CN101508663A (zh) | 一种间甲硫基二苯胺的合成方法 | |
| CN101353312B (zh) | 苯甘氨酸衍生物的合成 | |
| CN113461572B (zh) | 2-(3-溴-5-甲基苯基)乙腈的合成 | |
| CN113072471B (zh) | 一种利非司特中间体及其制备方法 | |
| Zupet et al. | Some transformations of alkyl heteroarylpyruvates | |
| CN119431200A (zh) | 一种依托考昔中间体的合成方法 | |
| CN104788474B (zh) | 一种三氮唑苯并噻嗪酮稠杂环的合成方法 | |
| CN1315781C (zh) | 制备4－氨基－1－萘酚醚类化合物的方法 | |
| CN105622522B (zh) | 一种瑞舒伐他汀钙关键中间体的合成方法 | |
| JP2003267945A (ja) | ヒドロキシルアミンｏ−置換体の製造方法 | |
| WO2015090160A1 (zh) | 用于制备4-(2‐(4‐甲基苯基硫基))苯基哌啶的化合物、其制备方法及应用 | |
| CN107353247A (zh) | 一种2‑芳基‑3‑酰氨基喹啉衍生物及其制备方法 | |
| JP2008007441A (ja) | ３−（ヒドロキシ又はアルコキシ）−４−アルコキシ−６−ニトロ安息香酸化合物の製法 | |
| CN105712939A (zh) | 一种合成瑞舒伐他汀钙关键中间体的方法 | |
| JPS584714B2 (ja) | ３−イソオキサゾリル尿素類の製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |